HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A A Ivashchenko Selected Research

AV0012

1/2014[Preclinical study of safety of the new pharmacological substance AV0012 to treat hepatitis C].
1/2014[Preclinical study of AV0012 early stage inhibitor of hepatitis C virus infection: I. In vitro ADME and pharmacokinetics].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A A Ivashchenko Research Topics

Disease

2Dengue (Dengue Fever)
01/2014 - 01/2014
2Virus Diseases (Viral Diseases)
01/2014 - 01/2014
2Infections
01/2014 - 01/2014
2Yellow Fever
01/2014 - 01/2014
1Hepatitis C
01/2014
1Hepatocellular Carcinoma (Hepatoma)
01/2014
1Human Influenza (Influenza)
01/2014
1West Nile Fever
01/2014
1Paramyxoviridae Infections (Parainfluenza)
01/2014
1Diarrhea
01/2014
1Venezuelan Equine Encephalomyelitis
01/2014

Drug/Important Bio-Agent (IBA)

2AV0012IBA
01/2014 - 01/2014
1RNA (Ribonucleic Acid)IBA
01/2014
1AVR-560IBA
01/2014
1indoleIBA
01/2014
1Blood Proteins (Serum Proteins)IBA
01/2014